β-tubulin III and IV expression as predictive factors for overall survival after paclitaxet therapy in patients with heavily pre-treated metastatic breast cancer.

被引：0
|
作者：
Kendzierski, N.
Mangia, A.
Ulbrich, E. J.
Strauss, H. G.
Thomssen, C.
Paradiso, A.
机构：
[1] Univ Halle Wittenberg, Halle, Germany
[2] Natl Canc Inst, Bari, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial
    Aftimos, P. G.
    Turner, N.
    O'Shaughnessy, J.
    van den Tweel, E.
    Oesterholt, M.
    Escriva-de-Romani, S.
    Tueux, N. Quenel
    Tan, T. J. Y.
    Lim, J.
    Ladoire, S.
    Armstronh, A. C.
    Stradella, A.
    Bianchi, G. V.
    Colleoni, M. A.
    Kaczmarek, E.
    Punie, K.
    Song, X.
    Koper, N.
    Saura Manich, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S340 - S341
  • [32] Locoregional therapy targeted at the primary tumour improves overall survival in patients with stage IV metastatic breast cancer: A systematic review and meta-analysis with 185942 patients
    Gera, R.
    Mokbel, K.
    Chehade, H. El Hage
    Wazir, U.
    Tayeh, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 52 - 53
  • [33] Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival
    White, Jennifer
    Elemary, Mohamed
    Linn, Swe Mar
    Novitzky-Basso, Igor
    Xenocostas, Anargyros
    Hamad, Nada
    Culos, Samantha
    Tan, Sui
    Law, Arjun
    Kumar, Rajat
    Mattsson, Jonas
    Dennis, Dong
    Kim, Hwan, Sr.
    BLOOD, 2021, 138
  • [34] Ixabepilone plus capecitabine improves overall survival in symptomatic patients with metastatic breast cancer previously treated with anthracycline and taxane in 2 large phase III studies.
    Conte, P.
    Roche, H.
    Perez, E.
    Sparono, J.
    Xu, B.
    Jassem, J.
    Peck, R.
    Mukhopadhyay, P.
    Hortobagyi, G.
    CANCER RESEARCH, 2009, 69 (02) : 381S - 382S
  • [35] Risk factors for relapse free and overall survival in the second decade after surgery in patients with early breast cancer not receiving adjuvant hormonal therapy
    Kuhar, Cvetka Grasic
    Zakotnik, Branko
    ANNALS OF ONCOLOGY, 2007, 18 : 161 - 161
  • [36] A PREDICTIVE PATIENT-LEVEL SURROGACY MODEL BETWEEN PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH PRE-TREATED ADVANCED OR METASTATIC (A/M) NON-SMALL-CELL LUNG CANCER (NSCLC) WITH A KRASG12C MUTATION
    Berardi, A.
    Maciel, D.
    Cope, S.
    Mastikhina, L.
    Lee, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [37] Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients
    Kesavan, Murali
    Meyrick, Danielle
    Gallyamov, Marat
    Turner, J. Harvey
    Yeo, Sharon
    Cardaci, Giuseppe
    Lenzo, Nat P.
    DIAGNOSTICS, 2021, 11 (03)
  • [38] Overall survival analysis of a randomized phase III trial comparing nab-paclitaxel with solvent-based paclitaxel in patients with metastatic breast cancer previously treated with anthracycline
    Davidson, N.
    Tjulandin, S.
    O'Shaughnessy, J.
    Bhar, P.
    Gradishar, W.
    EJC SUPPLEMENTS, 2008, 6 (07): : 218 - 218
  • [39] Factors predictive of tumor recurrence and overall survival in patients with esophageal cancer who have pathologic complete response after neo-adjuvant therapy.
    Gangi, Alexandra
    Hoffe, Sarah E.
    Frakes, Jessica M.
    Almhanna, Khaldoun
    Pena, Luis
    Fontaine, Jacques
    Blackham, Aaron Udell
    Pimiento, Jose Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [40] Prognostic factors predicting overal survival after radiotherapy for metastatic spinal cord compression in breast cancer patients treated in the Brazilian public health system
    Reinert, Tomas
    Zylberberg, Ricardo
    Lima, Frederico M. T.
    Pinto, Christiane S.
    Boukai, Alexandre
    CANCER RESEARCH, 2015, 75
12345